reviewTop 1% cited
Obesity and dyslipidemia
Metabolism · 2018 · Vol. 92 · pp. 71–81
Jelena Vekić✉(University of Belgrade)Aleksandra Zeljković(University of Belgrade)Aleksandra Stefanović(University of Belgrade)Zorana Jelić‐Ivanović(University of Belgrade)Vesna Spasojević‐Kalimanovska(University of Belgrade)
Peroxisome Proliferator-Activated ReceptorsCholesterol and Lipid MetabolismLipid metabolism and disordersDyslipidemiaPCSK9AdipokineMedicineObesityInsulin resistanceInternal medicineBioinformaticsEndocrinologyBiology
MeSH terms
Cardiovascular DiseasesHumansObesityBiomarkersDyslipidemias
Funding
- European Cooperation in Science and Technology
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Citations
606
FWCI
11.69
field-weighted impact
References
178
Percentile
99%
vs. same field & year
Citations per year
References
Dyslipidemia in Obesity: Mechanisms and Potential Targets
Nutrients · 2013 · 1,637 citations
Adiponectin: mechanistic insights and clinical implications
Diabetologia · 2012 · 624 citations
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Nature Cell Biology · 2011 · 2,678 citations
NF-κB, Inflammation, and Metabolic Disease
Cell Metabolism · 2011 · 1,880 citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
European Heart Journal · 2016 · 3,169 citations
Mechanisms of Insulin Action and Insulin Resistance
Physiological Reviews · 2018 · 2,790 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.